Objective: The objective of this study was to use array comparative genomic hybridization to detect causal microdeletions in samples of subjects with cleft lip and palate.
Identification of microdeletion syndromes began with the recognition that syndromic phenotypes often are associated with mental retardation. One of the first classic chromosomal microdeletion syndromes identified was 4p2 (Wolf-Hirschhorn) syndrome (Hirschhorn et al., 1965) in which cleft lip and/or palate is a common feature (Battaglia et al., 2008) . Our ability to detect chromosomal microdeletion syndromes is evolving and is greatly enhanced by the use of more advanced molecular technologies, especially the use of microarrays.
The 3q29 syndrome was first described by Willatt et al. (2005) in six patients who presented with mild to moderate mental retardation, with the only slightly dysmorphic facial features common to most of these patients: a long and narrow face, short philtrum, and high nasal bridge. Autism, gait ataxia, chest-wall deformity, and long and tapered fingers were noted in at least two of the six patients, and some additional features, including microcephaly, cleft lip and palate (CLP), horseshoe kidney and hypospadias, ligamentous laxity, recurrent middle ear infections, and abnormal pigmentation were described also (Willatt et al., 2005) . In addition, 19 other cases have been reported; all of the individuals presented with ear abnormalities, mental retardation, microcephaly, and various other features (Baynam et al., 2006; Krepischi-Santos et al., 2006; Ballif et al., 2008; Li et al., 2009; Pollazzon et al., 2009; Tyshchenko et al., 2009) .
We report a new case of 3q29 microdeletion syndrome involving cleft lip identified with the use of AffymetrixH Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA) that has a 1.5-million base pairs (Mbp) microdeletion at the 3q29 region inherited from a mosaic and unaffected father. To our knowledge, this is the first case of mosaicism involving the 3q29 microdeletion syndrome and the second case to present with cleft lip with or without cleft palate. Table 1 shows a summary of all published cases so far and their phenotypic features, including this new case.
Over the past few years, mosaicism of germline and somatic cells has been reported as an important mechanism leading to genetic disease. There have been several clinical descriptions of families in which affected children were born to unaffected parents with no family history of the disease, including cases of microdeletion syndromes; in some cases one of the unaffected parents were an asymptomatic mosaic for the microdeletion. The 22q11 region is the most commonly reported microdeletion region showing cases of mosaicism in unaffected parents; 22q deletions are variously known as velocardiofacial syndrome (OMIM #192430) (Sandrin-Garcia et al., 2002), DiGeorge syndrome (OMIM #188400) (Kasprzak et al., 1998) , and 22q11 deletion syndrome (Hatchwell et al., 1998; Saitta et al., 2004; Blennow et al., 2008; Halder et al., 2008) . Other examples of microdeletion syndromes include 22q13.3 deletion syndrome (OMIM #606232) (Phelan et al., 2001) and Smith-Magenis syndrome due to a deletion on chromosome region 17p11.2-q12 inherited from a mother who has mosaicism (Zori et al., 1993) .
On occasion, research produces individual results that bring to light significant health implications. It is generally recognized that research results should be offered to patients if the one or more of the following criteria is met: (1) analytical validity, (2) the associated risk for the disease is significant, (3) the disease has important health implications and/or carry significant reproductive risks, and (4) there are therapeutic or prevention interventions available (Bookman et al., 2006) . The results of this study have noteworthy implications for the family's reproductive risks because the father carries an elevated risk to have subsequent children with a 3q29 microdeletion syndrome due to the mosaicism. These results also allow for anticipatory guidance focusing on the range of possible clinical outcomes and associated available treatments that can be offered to the family for this child and subsequent children.
MATERIAL AND METHODS
The male patient was the second child of healthy parents and was seen during surgical screening for an Operation Smile medical mission in the Philippines (Murray et al., 1997) . At the time of the patient's birth, the mother was 19 years old and the father was 28 years old. The family history shows a maternal seventh-degree relative with an oral cleft, but the specific type of cleft is not known. The patient was delivered at home by a midwife. Physical examination at 18 months of age showed broad nasal root, unilateral right-sided cleft lip, complete syndactyly of third and fourth toes on the right foot, and cup-shaped ears with thickened helices, as shown in Figure 1 . Due to the limited time available when screening patients for surgery, an evaluation of the child for internal anomalies and cognitive delay was not possible. DNA was obtained using standard techniques from blood from the child and both parents following signed informed consent (IRB No. 199804081 and IRB No. 00003930) .
DNA Microarray Analysis
The microdeletion was detected by a genome-wide copy number scan that was initially performed on a DNA sample from the proband and subsequently from the father using the AffymetrixH Genome-Wide Human SNP Array 6.0 (Affymetrix). These arrays offer a good genome-wide coverage, with almost 2 million single nucleotide polymorphisms (SNP) and copy number variation (CNV) probes, and measure DNA copy number differences between a reference genome and the sample genome. The results were analyzed using the Partek Genomics Suite (Partek, Inc., St. Louis, MO) and Affymetrix Genotyping Console software.
SNP Sequencing
Following the array analysis, we sequenced 43 known SNPs at the apparent boundaries and inside the microdeletion region in DNA from the parents and child, looking for evidence of non-Mendelian transmissions from parent to child. We adopted the Conrad et al. (2006) method of classification of transmission pattern. By this method we categorized each transmission event into the following groups: A and B, Mendelian inconsistency compatible with potential deletion of the maternal or paternal alleles, respectively; C, Mendelian inconsistency indicating no deletion transmission; D, consistent with Mendelian inheritance with no information on potential deletions; E and F, consistent with Mendelian inheritance and compatible with potential deletion of the maternal or paternal alleles, respectively; and G, consistent with Mendelian inheritance and indicating no deletion transmission. Patterns A and B are informative for potential deletion transmission. Patterns A and E are supportive of maternal transmission of a deleted allele; whereas, patterns B and F are supportive of paternal transmission.
Quantitative Real-Time Polymerase Chain Reaction
The quantitative real-time polymerase chain reaction (PCR) was performed with DNA from the proband, father, mother, and a normal control using DNA-binding dye SYBR Green I. This method enables both detection and quantification as absolute number of copies of a specific sequence in a DNA sample. We designed three different sets of primers located inside the deletion region and one set of primers in a different chromosome as reference control. All the samples were analyzed in duplicate.
The fold changes per sample were calculated based on methods previously described (Weksberg et al., 2005) . We compared the target samples (proband and father) with normal reference controls to obtain the fold changes. (Weksberg et al., 2005) .
RESULTS
The microarray analysis revealed a 1.5-Mbp microdeletion in the proband encompassing 22 genes, including DLG1 and PAK2. The deletion is at the same chromosomal location as the previous published cases of 3q29 microdeletion syndrome (Willatt et al., 2005) . After the microarray analysis we sequenced 43 SNPs at the apparent boundaries and inside the microdeletion in DNA from the parents and child, looking for evidence of non-Mendelian transmissions from parent to child. Five SNPs showed Mendelian inconsistency compatible with deletion on the paternal chromosome (the remaining SNPs were not informative); no heterozygous genotypes were seen in the proband. Figure 2 shows details of the deleted region. Based on the SNP sequencing results, we analyzed the father's DNA sample with the AffymetrixH Genome-Wide Human SNP Array 6.0 (Affymetrix) to assess the father's status for the microdeletion. Surprisingly, the father's DNA analysis showed the same 1.5-Mbp microdeletion at the chromosomal region 3q29, and due to his normal phenotype the hypothesis of parental mosaicism for the microdeletion was tested.
The quantitative real-time PCR results supported the mosaicism hypothesis, showing a different amplification pattern for the proband and father when compared with normal controls. We observed a reduction in relative copy number in these two samples, but the father's reduction was smaller than the proband's, indicating that a higher number of copies were present in the father's sample compared with the proband's. Fold-change calculations revealed DKC t consistent with loss of one copy in the proband and loss of 0.4 copies in the father that are consistent with mosaicism of about 40% in the DNA extracted from the father's white blood cells. No other paternal tissues were available for analysis. The mother's sample had normal values. A summary of the quantitative PCR method is presented in Figure 3 . Table 2 shows the copy number calculation where C t represents the point at which the fluorescence crosses the threshold; KC t is the corrected C t value; and DKC t represents copy number gain or loss per sample (fold changes). The analysis show DKC t values consistent with loss of one and 0.44 copies for the proband and father, respectively.
DISCUSSION AND CONCLUSION
Sometimes clinical features associated with a known syndrome may not be typical or specific enough to make a diagnosis based only on the phenotypic presentation. In such cases, advances in molecular technologies can improve the detection of chromosomal abnormalities such as microduplications and/or microdeletions that have an etiologic role. Microdeletion and microduplication genetic syndromes are known to be a significant cause of developmental delay and dysmorphology (Lisi et al., 2008) ; current predictions, based on array comparative genomic hybridization (a-CGH), estimate that 10% to 20% of individuals with mental retardation and dysmorphic features have a chromosomal imbalance (Koolen et al., 2006; Rosenberg et al., 2006; Lupski, 2007) .
The current generation of DNA microarrays such as that from Affymetrix used in this study offer excellent genomewide coverage, with almost 2 million SNPs and CNV probes, and measure DNA copy number differences between a reference genome and the sample genome. It is possible to determine breakpoints at ultrahigh resolution in DNA targets, helping to localize with good precision the boundaries of any microdeletion that may be causative of anomalies such as the 3q29 microdeletion reported here.
This microdeletion is 1.5 Mbp in length and encompasses 22 genes, including PAK2 and DLG1, which are autosomal homologues of two known X-linked mental retardation genes, PAK3 and DLG3, and are in the same region reported previously (Willatt et al., 2005) in six patients with 3q29 syndrome. Previous reports show that mutations that cause loss of function in PAK3 and DLG3 result in moderate to severe mental retardation (Allen et al., 1998; Tarpey et al., 2004) , and a recent animal model study with DLG1 gene reported that mutant mice exhibit growth retardation and craniofacial abnormalities (Mahoney et al., 2006) .
The 3q29 microdeletion syndrome phenotype is variable, making the clinical diagnosis challenging; it can include a long and narrow face, short philtrum, high nasal bridge, and cleft lip and palate. We documented dysmorphic features in our patient but were unable to complete a neurocognitive assessment. Given that all patients with 3q29 microdeletion reported thus far were found to have some form of developmental delay and/or autism, it is likely that our patient is also at risk for similar outcomes. To our knowledge, we reported the second case presenting with cleft lip and the first case of this microdeletion inherited from a parent with mosaicism presenting with a normal phenotype.
Although the general goal of fundamental genetic research is to produce generalizable knowledge, occasionally the research produces individual results that carry significant health implications. The presence of mosaicism in an unaffected parent has major implications for genetic counseling because the potential recurrence risk of transmission is not commonly predicted in apparently de novo cases; usually mosaicism is identified when the mutation is transmitted to more than one child born to normal parents. Once present, the parental mosaicism for the genomic abnormality raises the chance of having an affected child.
Sharing findings with participant families is sometimes complicated due to ethical, cultural, and geographical issues. Our study is under the purview of two separate institutional review boards (IRBs), one in the Philippines and one in the United States, each having oversight of different components of the research project. The IRBs do not coordinate their review activities. In order to release the research results we must interpret and satisfy the standards and procedures of two separate IRBs; this may cause significant delays in our ability to report results in a timely manner and may even result in conflicting views on whether such information should be returned to the affected family. In addition, the family has limited access to medical centers where genetic counseling and prenatal diagnosis services are available. Communicating results to the family and explaining the cause of their child's CLP is impaired by language differences and possible cultural differences the family may have (Daack-Hirsch, 2010) . Despite these barriers we believe that in this situation the ethical principles of beneficence, respect of persons, and justice obligate the researchers to make results available to the participant families (Knoppers et al., 2006) .
We believe the best way to make the results available for the family of our study is to first obtain the appropriate IRB approvals and to collaborate with geneticists from the Philippines. This strategy promotes a culturally sensitive way to deal with access to care, language, and the limited availability of services. We recommend that investigators engaging in cross-cultural human genetics research studies include a health care provider as an active member of their research team in order to plan for culturally appropriate strategies to report clinically significant research results. We also recommend that a plan for reporting research results is included in the IRB protocols for each IRB involved and that the consent forms reflect options for dealing with the research subject's right to choose whether or not he or she wishes to receive the results.
Our findings confirm the usefulness of a-CGH to detect causal microdeletions; indicate that parental somatic mosaicism should be considered in healthy parents for a more accurate estimate of the recurrence risk and genetic counseling of the families; and present important ethical implications of sharing health impact results from research studies with the participants' families.
FIGURE 3 Confirmation of the microarray results and detection of mosaicism by quantitative PCR using three sets of primers inside the deleted region and one set of primers in a normal control region. The plots show a different pattern of amplification for control, father, and proband samples. The control samples amplifies normally; whereas, the proband sample presents the higher delay of amplification due to the deletion, and the father presents a intermediate delay due to the presence of both deleted and normal cells supporting the hypothesis of mosaicism. 
